Abstract 13962: Precision Pharmacological Treatment for Obstructive Hypertrophic Cardiomyopathy With Mavacamten: One-Year Results From PIONEER-OLE
2019
Introduction: Despite the well-established need for disease-specific pharmacological therapies in hypertrophic cardiomyopathy (HCM), there has been little success to date. Mavacamten (Mava), a targ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI